UA35636C2 - Поліпептид, який має активність легеневої поверхнево-активної речовини, та фармацевтична композиція для лікування респіраторного дистрес-синдрому у ссавців - Google Patents

Поліпептид, який має активність легеневої поверхнево-активної речовини, та фармацевтична композиція для лікування респіраторного дистрес-синдрому у ссавців

Info

Publication number
UA35636C2
UA35636C2 UA96114479A UA96114479A UA35636C2 UA 35636 C2 UA35636 C2 UA 35636C2 UA 96114479 A UA96114479 A UA 96114479A UA 96114479 A UA96114479 A UA 96114479A UA 35636 C2 UA35636 C2 UA 35636C2
Authority
UA
Ukraine
Prior art keywords
leu
mammals
val
pharmaceutical composition
ile
Prior art date
Application number
UA96114479A
Other languages
English (en)
Russian (ru)
Inventor
Рюдігер Наве
Рюдигер Наве
Вольф-Рюдігер Ульріх
Вольф-Рюдигер Ульрих
Ернст Штурм
Эрнст Штурм
Уве Крюгєр
Уве Крюгер
Дітріх ХЕФНЄР
Дитрих Хефнер
Original Assignee
Бик Гульден Ломберг Хеміше Фабрік Гмбх
Бик Гульден Ломберг Хемише Фабрик ГмбХ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6519392&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA35636(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Бик Гульден Ломберг Хеміше Фабрік Гмбх, Бик Гульден Ломберг Хемише Фабрик ГмбХ filed Critical Бик Гульден Ломберг Хеміше Фабрік Гмбх
Publication of UA35636C2 publication Critical patent/UA35636C2/uk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

Винахід належить до легеневих поверхнево-активних поліпептидів, способу їх отримання і до композицій, що містять їх. Поліпептид з активністю легеневої поверхнево-активної речовини, загальної формули I: 0 1 2 3 4 5 6 7 8 9 10 (A) Gly Ile Pro B B Pro Val His Leu Lys 11 12 13 14 15 16 17 18 19 20 Arg Leu Leu Ile Val Val Val Val Val Val 21 22 23 24 25 26 27 28 29 30 Leu Ile Val Val Val Ile Val Gly Ala Leu 31 32 33 34 Leu C Gly Leu (1) де А означає Н або Phe, В означає Phe або Тгр і С означає Ile, Leu або Ser.
UA96114479A 1994-05-31 1995-05-27 Поліпептид, який має активність легеневої поверхнево-активної речовини, та фармацевтична композиція для лікування респіраторного дистрес-синдрому у ссавців UA35636C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4418936A DE4418936A1 (de) 1994-05-31 1994-05-31 Polypeptid
PCT/EP1995/002028 WO1995032992A1 (de) 1994-05-31 1995-05-27 Synthetische peptidanaloge des lungenoberflächenproteins sp-c

Publications (1)

Publication Number Publication Date
UA35636C2 true UA35636C2 (uk) 2001-04-16

Family

ID=6519392

Family Applications (1)

Application Number Title Priority Date Filing Date
UA96114479A UA35636C2 (uk) 1994-05-31 1995-05-27 Поліпептид, який має активність легеневої поверхнево-активної речовини, та фармацевтична композиція для лікування респіраторного дистрес-синдрому у ссавців

Country Status (29)

Country Link
US (1) US5874406A (uk)
EP (1) EP0764172B1 (uk)
JP (1) JP3359638B2 (uk)
KR (1) KR100355626B1 (uk)
CN (1) CN1130374C (uk)
AT (1) ATE275154T1 (uk)
AU (1) AU690280B2 (uk)
BG (1) BG63210B1 (uk)
BR (1) BR9507811B1 (uk)
CA (1) CA2191344C (uk)
CY (1) CY2552B1 (uk)
CZ (1) CZ286976B6 (uk)
DE (2) DE4418936A1 (uk)
DK (1) DK0764172T3 (uk)
EE (1) EE03775B1 (uk)
ES (1) ES2227548T3 (uk)
FI (1) FI118126B (uk)
HK (1) HK1000891A1 (uk)
HU (1) HU220191B (uk)
NO (1) NO317149B1 (uk)
NZ (1) NZ287447A (uk)
PL (1) PL181234B1 (uk)
PT (1) PT764172E (uk)
RO (1) RO118752B1 (uk)
RU (1) RU2145611C1 (uk)
SI (1) SI0764172T1 (uk)
SK (1) SK282441B6 (uk)
UA (1) UA35636C2 (uk)
WO (1) WO1995032992A1 (uk)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997035882A1 (en) * 1996-03-27 1997-10-02 Ortho Pharmaceutical Corporation Lyophilized pulmonary surfactant peptide compositions
DE19851119C2 (de) 1998-11-06 2001-05-31 Byk Gulden Lomberg Chem Fab Behälter und Vorrichtung zur Blindung der Verabreichung von nicht festen pharmazeutischen Darreichungsformen bei der klinischen Prüfung
IT1308180B1 (it) * 1999-02-12 2001-12-07 Chiesi Farma Spa Peptidi sintetici aventi la capacita' di diminuire la tensionesuperficiale e loro impiego nella preparazione di un surfattante
WO2000076535A1 (en) * 1999-06-11 2000-12-21 Byk Gulden Lomberg Chemische Fabrik Gmbh Pharmaceutical preparation containing modifications of surfactant protein b (sp-b) and surfactant protein c (sp-c)
SI1192184T1 (sl) * 1999-06-17 2007-06-30 Nycomed Gmbh Estri surfakantnega proteina C
WO2001019392A1 (en) 1999-09-16 2001-03-22 Byk Gulden Lomberg Chemische Fabrik Gmbh Combination of c1-inh and lung surfactant for the treatment of respiratory disorders
WO2001039573A2 (de) * 1999-12-01 2001-06-07 Byk Gulden Lomberg Chemische Fabrik Gmbh Verwendung von lungensurfactant zur behandlung von legionärskrankheit
EP1259222A1 (en) * 2000-02-11 2002-11-27 ALTANA Pharma AG Novel use of pulmonary surfactant for the prophylaxis and treatment of chronic pulmonary diseases
US6660833B1 (en) 2000-02-29 2003-12-09 Harbor-Ucla Research And Education Institute Respiratory distress syndrome therapy with peptide analogs of human SP-B
US20040254112A1 (en) * 2000-04-12 2004-12-16 Dietrich Hafner Use of pulmonary surfactant for the early treatment of acute pulmonary diseases
DE10018022A1 (de) * 2000-04-12 2001-10-31 Byk Gulden Lomberg Chem Fab Neue Verwendung von Lungensurfactant zur Prophylaxe oder Frühbehandlung von akuten Lungenerkrankungen
JP2003530356A (ja) * 2000-04-12 2003-10-14 アルタナ ファルマ アクチエンゲゼルシャフト 急性肺疾患の予防又は早期治療のための肺表面活性物質の新規使用
CA2463459C (en) 2001-10-11 2013-06-18 Altana Pharma Ag Novel use of pulmonary surfactant
AU2002357168A1 (en) 2001-12-12 2003-07-09 Penn State Research Foundation Surfactant prevention of lung complications from cancer chemotherapy
ATE457736T1 (de) * 2004-08-06 2010-03-15 Nycomed Gmbh Zusammensetzung aus einem pulmonalen surfactant und einem von tnf stammenden peptid
US7464012B2 (en) * 2004-12-10 2008-12-09 L'air Liquide, Societe Anonyme A Directoire Et Conseil De Surveillance Pour L'etude Et L'exploitation Des Procedes Georges Claude Simplified process simulator
US7582312B2 (en) 2004-11-15 2009-09-01 Discovery Laboratories, Inc. Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof
US8337815B2 (en) 2004-12-23 2012-12-25 Discovery Laboratories, Inc. Pulmonary surfactant formulations
JP2008526868A (ja) 2005-01-06 2008-07-24 ディスカバリー ラボラトリーズ，インコーポレイテッド 表面活性剤処置療法
DE102005014650B3 (de) 2005-03-31 2006-08-17 Altana Pharma Ag Anordnung aus Katheter und Anschlussstück sowie Ventil zum Durchführen eines Katheters
DE102005016229B3 (de) 2005-04-08 2006-06-14 Altana Pharma Ag Trockenvernebler
US8221772B2 (en) * 2006-09-19 2012-07-17 Discovery Laboratories Inc. Pulmonary surfactant formulations and methods for promoting mucus clearance
US7951781B2 (en) 2006-11-02 2011-05-31 University Of Iowa Research Foundation Methods and compositions related to PLUNC surfactant polypeptides
EP2009023A1 (en) * 2007-06-04 2008-12-31 Rentschler Beteiligungs GmbH Novel peptides and their use for the treatment of edema
US8048043B2 (en) 2007-06-08 2011-11-01 Chiesi Farmaceutici S. P. A. Method of administration of a pulmonary surfactant
EP2370068A4 (en) 2008-12-10 2015-09-23 Paka Pulmonary Pharmaceuticals Inc METHOD AND COMPOSITIONS FOR DELIVERING MEDICAMENTS TO THE LUNG
EP2475373B1 (en) 2009-09-08 2013-11-13 Chiesi Farmaceutici S.p.A. A therapeutic combination comprising a pulmonary surfactant and antioxidant enzymes
JP6324069B2 (ja) * 2010-08-23 2018-05-16 フラウンホーファー−ゲゼルシャフト ツル フェルデルング デル アンゲヴァンテン フォルシュング エー ファウＦｒａｕｎｈｏｆｅｒ−Ｇｅｓｅｌｌｓｃｈａｆｔ ｚｕｒ Ｆｏｅｒｄｅｒｕｎｇ ｄｅｒ ａｎｇｅｗａｎｄｔｅｎ Ｆｏｒｓｃｈｕｎｇ ｅ．Ｖ． 治療学的に有効な物質を含む加湿された粒子
EP2812018B1 (en) 2012-02-09 2018-12-05 University Of Rochester Novel sp-b&sp-c peptides, synthetic lung surfactants, and use thereof
US20130303726A1 (en) * 2012-04-17 2013-11-14 Chiesi Farmaceutici S.P.A. Method for the preparation of surfactant peptides
WO2013188016A2 (en) 2012-05-04 2013-12-19 Discovery Laboratories, Inc. Surfactant therapy for exposure to ionizing radiation
ES2674797T3 (es) 2014-03-05 2018-07-04 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Humidificador para humedecer un aerosol
WO2016170087A1 (en) 2015-04-22 2016-10-27 Chiesi Farmaceutici S.P.A Method and system for effective breath-synchronized delivery of medicament to the lungs
EP3106090A1 (en) 2015-06-15 2016-12-21 CHIESI FARMACEUTICI S.p.A. System for effective breath-synchronized delivery of medicament to the lungs
WO2016173634A1 (en) 2015-04-28 2016-11-03 Chiesi Farmaceutici S.P.A Device for facilitating the administration of a medicament to the lung by a catheter
JP2018514545A (ja) 2015-04-30 2018-06-07 ユニバーシティ オブ ブレーメン 医療用および美容用の新規な皮膚ケア製造物
CA3028551A1 (en) 2016-07-28 2018-02-01 Chiesi Farmaceutici S.P.A. Method and system for delivery of an aerosolized medicament
BR112019008169A2 (pt) 2016-10-26 2019-07-09 Chiesi Farm Spa dispositivo para facilitar o posicionamento de um cateter, sistema para entrega de um medicamento em aerossol por meio de um cateter, método para utilização de um dispositivo e kit
CN110099695B (zh) 2016-12-22 2022-01-25 奇斯药制品公司 用于治疗进展性bpd的包含肺表面活性物质和类固醇的治疗组合
CN107163148A (zh) * 2017-05-15 2017-09-15 重庆理工大学 肺表面活性蛋白b前肽的重组蛋白及其制备方法和应用
TW201927286A (zh) 2017-12-15 2019-07-16 義大利商凱西製藥公司 用於噴霧投藥之包含肺表面張力素的藥學調配物
WO2019115771A1 (en) 2017-12-15 2019-06-20 Pari Pharma Gmbh Nebuliser system, holding system, combination comprising nebuliser system and holding system, and aerosol administration method
AU2019260526A1 (en) 2018-04-23 2020-11-19 Chiesi Farmaceutici S.P.A. A therapeutic combination comprising a pulmonary surfactant and a steroid for the prophylaxis of BPD
CN109001466A (zh) * 2018-07-19 2018-12-14 新疆维吾尔自治区人民医院 一种用于osa的肺表面活性蛋白试剂盒及其应用
EP3666315A1 (en) 2018-12-14 2020-06-17 PARI Pharma GmbH Aerosol delivery device and method of operating the aerosol delivery device
EP3666316A1 (en) 2018-12-14 2020-06-17 PARI Pharma GmbH Aerosol delivery device and method of operating the aerosol delivery device
EP3843105A1 (en) 2019-12-23 2021-06-30 PARI Pharma GmbH Control device for aerosol nebulizer system
EP4097128A1 (en) 2020-01-28 2022-12-07 Chiesi Farmaceutici S.p.A. Polypeptides having improved properties
EP4411745A1 (en) 2023-02-01 2024-08-07 Pari Medical Holding GmbH Medical evaluation method, aerosol nebulizer and medical evaluation system

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59164724A (ja) * 1983-03-10 1984-09-17 Tokyo Tanabe Co Ltd サ−フアクタント及びそれを含有する呼吸窮迫症候群治療剤
US4933280A (en) * 1984-12-11 1990-06-12 California Biotechnology Inc. Recombinant DNA sequence encoding Alveolar Surfactant Protein
US4659805A (en) * 1984-12-11 1987-04-21 California Biotechnology, Inc. Recombinant alveolar surfactant protein
US5104853A (en) * 1984-12-11 1992-04-14 California Biotechnology Inc. Alveolar surfactant proteins having cys to ser mutations
US5169761A (en) * 1984-12-11 1992-12-08 California Biotechnology Inc. Dna encoding and expression systems for alveolar surfactant proteins
US5013720A (en) * 1986-05-06 1991-05-07 Abbott Laboratories SAP-6-Val proteins and methods
ATE163013T1 (de) * 1987-11-04 1998-02-15 Byk Gulden Lomberg Chem Fab Alveolare oberflächenaktive proteine
SE8803713D0 (sv) * 1988-10-18 1988-10-18 Kabigen Ab Biologically active lipoprotein and its use
DE3921954A1 (de) * 1989-07-04 1991-01-17 Thomae Gmbh Dr K Niedrig-viskose, hochkonzentrierte surfactant-suspension
JPH05294996A (ja) * 1992-04-17 1993-11-09 Tokyo Tanabe Co Ltd 合成ペプチド、それを含有する肺サーファクタント及び呼吸窮迫症候群治療剤

Also Published As

Publication number Publication date
ES2227548T3 (es) 2005-04-01
MX9605986A (es) 1998-06-30
NO317149B1 (no) 2004-08-30
NZ287447A (en) 1998-01-26
PL181234B1 (pl) 2001-06-29
FI118126B (fi) 2007-07-13
SK282441B6 (sk) 2002-02-05
BR9507811A (pt) 1997-09-16
US5874406A (en) 1999-02-23
KR970703367A (ko) 1997-07-03
KR100355626B1 (ko) 2002-12-26
BG101028A (en) 1998-01-30
PT764172E (pt) 2005-01-31
JPH10504025A (ja) 1998-04-14
CZ286976B6 (en) 2000-08-16
BR9507811B1 (pt) 2009-05-05
SK152496A3 (en) 1997-06-04
NO965052L (no) 1997-01-28
NO965052D0 (no) 1996-11-27
CA2191344A1 (en) 1995-12-07
EE9600175A (et) 1997-06-16
DE4418936A1 (de) 1996-02-08
RO118752B1 (ro) 2003-10-30
AU690280B2 (en) 1998-04-23
WO1995032992A1 (de) 1995-12-07
DE59510941D1 (de) 2004-10-07
PL317420A1 (en) 1997-04-14
FI964766A (fi) 1996-11-29
CY2552B1 (en) 2008-07-02
CA2191344C (en) 2003-04-08
JP3359638B2 (ja) 2002-12-24
ATE275154T1 (de) 2004-09-15
SI0764172T1 (en) 2005-02-28
CN1130374C (zh) 2003-12-10
EP0764172A1 (de) 1997-03-26
AU2616995A (en) 1995-12-21
HU9603249D0 (en) 1997-01-28
FI964766A0 (fi) 1996-11-29
HK1000891A1 (en) 2004-09-17
HUT76952A (hu) 1998-01-28
CZ350296A3 (en) 1997-05-14
EE03775B1 (et) 2002-06-17
HU220191B (hu) 2001-11-28
CN1154117A (zh) 1997-07-09
EP0764172B1 (de) 2004-09-01
DK0764172T3 (da) 2005-01-10
BG63210B1 (bg) 2001-06-29
RU2145611C1 (ru) 2000-02-20

Similar Documents

Publication Publication Date Title
UA35636C2 (uk) Поліпептид, який має активність легеневої поверхнево-активної речовини, та фармацевтична композиція для лікування респіраторного дистрес-синдрому у ссавців
IL104314A0 (en) Human kunitz-type protease inhibitor and variants thereof,their production and pharmaceutical compositions containing them
MX9703643A (es) Metodos para tratamiento de esclerosis multiple usando analogos de peptidos de proteina basica de mielina humana.
AU6020099A (en) Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein
MD1652G2 (ro) Proteină cu activitate de tip citochină, ADN recombinant, codificator pentru această proteină, celule şi microorganisme transformate, vector de expresie, procedeu de obţinere a proteinei şi remediu care conţine această proteină
WO1996028470A3 (en) Peptide analogues of human myelin basic protein useful in treating multiple sclerosis
DE3261304D1 (en) Retro-inverso analogues of c-terminal penta and hexapeptides of substance p.
HUT58765A (en) Process for producing peptide compounds and pharmaceutical compositions containing them as active components
EP0161007A3 (en) Retro - inverso c-terminal hexapeptide analogues of substance p
AU682638B2 (en) Peptide, bronchodilator and blood flow ameliorant
AU586647B2 (en) Improvements in or relating to peptides that inhibit renin
GR3015492T3 (en) ZNS-active hexapeptides with antiamnestic activity.
RU94036002A (ru) Ингибитор протеазы, днк, вектор, клетка, способ получения ингибитора, фармацевтическая композиция